Early dengue virus interactions: the role of dendritic cells during infection

Virus Research

Volumn 223, Issue , 2016, Pages 88-98

  Santos Souza, Higo Fernando ^a   da Silva Almeida, Bianca ^a   Boscardin, Silvia Beatriz ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute of Science and Technology in Tropical Diseases   (Brazil)

Author keywords

Dendritic cells; Dengue fever; Immune responses; Surface receptors

Indexed keywords

CD209 ANTIGEN; FC RECEPTOR; CELL SURFACE RECEPTOR; PROTEIN BINDING; VIRAL PROTEIN;

DENDRITIC CELL; DENGUE; DENGUE VIRUS; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS ENTRY; ANIMAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS ATTACHMENT;

ANIMALS; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84978271669     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.07.001     Document Type: Review

References (127)

1. Acosta, E.G., Castilla, V., Damonte, E.B., Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell. Microbiol. 11:10 (2009), 1533–1549.
2. Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., Simon, V., Rodriguez-Madoz, J.R., Mulder, L.C., Barber, G.N., Fernandez-Sesma, A., DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog., 8(10), 2012, e1002934.
3. Anglero-Rodriguez, Y.I., Pantoja, P., Sariol, C.A., Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB kinase epsilon interaction. Clin. Vaccine Immunol. 21:1 (2014), 29–38.
4. Aye, K.S., Charngkaew, K., Win, N., Wai, K.Z., Moe, K., Punyadee, N., Thiemmeca, S., Suttitheptumrong, A., Sukpanichnant, S., Prida, M., Halstead, S.B., Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum. Pathol. 45:6 (2014), 1221–1233.
5. Bakker, A.B., Baker, E., Sutherland, G.R., Phillips, J.H., Lanier, L.L., Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 96:17 (1999), 9792–9796.
6. Balsitis, S.J., Coloma, J., Castro, G., Alava, A., Flores, D., McKerrow, J.H., Beatty, P.R., Harris, E., Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am. J. Trop. Med. Hyg. 80:3 (2009), 416–424.
7. Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity. Nature 392:6673 (1998), 245–252.
8. Beatty, P.R., Puerta-Guardo, H., Killingbeck, S.S., Glasner, D.R., Hopkins, K., Harris, E., Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med., 7(304), 2015, 304ra141.
9. Beltramello, M., Williams, K.L., Simmons, C.P., Macagno, A., Simonelli, L., Quyen, N.T., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P.R., de Silva, A.M., Rey, F.A., Varani, L., Whitehead, S.S., Diamond, M.S., Harris, E., Lanzavecchia, A., Sallusto, F., The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8:3 (2010), 271–283.
10. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Brownstein, J.S., Hoen, A.G., Sankoh, O., Myers, M.F., George, D.B., Jaenisch, T., Wint, G.R., Simmons, C.P., Scott, T.W., Farrar, J.J., Hay, S.I., The global distribution and burden of dengue. Nature 496:7446 (2013), 504–507.
11. Boonnak, K., Slike, B.M., Burgess, T.H., Mason, R.M., Wu, S.J., Sun, P., Porter, K., Rudiman, I.F., Yuwono, D., Puthavathana, P., Marovich, M.A., Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82:8 (2008), 3939–3951.
12. Boonnak, K., Dambach, K.M., Donofrio, G.C., Tassaneetrithep, B., Marovich, M.A., Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J. Virol. 85:4 (2011), 1671–1683.
13. Boonnak, K., Slike, B.M., Donofrio, G.C., Marovich, M.A., Human FcgammaRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. J. Immunol. 190:11 (2013), 5659–5665.
14. Boruchov, A.M., Heller, G., Veri, M.C., Bonvini, E., Ravetch, J.V., Young, J.W., Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 115:10 (2005), 2914–2923.
15. Cerny, D., Haniffa, M., Shin, A., Bigliardi, P., Tan, B.K., Lee, B., Poidinger, M., Tan, E.Y., Ginhoux, F., Fink, K., Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog., 10(12), 2014, e1004548.
16. Chambers, T.J., Tsai, T.F., Pervikov, Y., Monath, T.P., Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine 15:14 (1997), 1494–1502.
17. Chan, K.R., Zhang, S.L., Tan, H.C., Chan, Y.K., Chow, A., Lim, A.P., Vasudevan, S.G., Hanson, B.J., Ooi, E.E., Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc. Natl. Acad. Sci. U. S. A. 108:30 (2011), 12479–12484.
18. Chau, T.N., Quyen, N.T., Thuy, T.T., Tuan, N.M., Hoang, D.M., Dung, N.T., Lien le, B., Quy, N.T., Hieu, N.T., Hieu, L.T., Hien, T.T., Hung, N.T., Farrar, J., Simmons, C.P., Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 198:4 (2008), 516–524.
19. Chawla, T., Chan, K.R., Zhang, S.L., Tan, H.C., Lim, A.P., Hanson, B.J., Ooi, E.E., Dengue virus neutralization in cells expressing Fc gamma receptors. PLoS One, 8(5), 2013, e65231.
20. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J., Marks, R.M., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:8 (1997), 866–871.
21. Chen, Y.C., Wang, S.Y., King, C.C., Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol. 73:4 (1999), 2650–2657.
22. Chen, S.T., Lin, Y.L., Huang, M.T., Wu, M.F., Cheng, S.C., Lei, H.Y., Lee, C.K., Chiou, T.W., Wong, C.H., Hsieh, S.L., CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453:7195 (2008), 672–676.
23. Clyde, K., Kyle, J.L., Harris, E., Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol. 80:23 (2006), 11418–11431.
24. Cruz-Oliveira, C., Freire, J.M., Conceicao, T.M., Higa, L.M., Castanho, M.A., Da Poian, A.T., Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol. Rev. 39:2 (2015), 155–170.
25. Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., Chawansuntati, K., Malasit, P., Mongkolsapaya, J., Screaton, G., Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:5979 (2010), 745–748.
26. Dejnirattisai, W., Webb, A.I., Chan, V., Jumnainsong, A., Davidson, A., Mongkolsapaya, J., Screaton, G., Lectin switching during dengue virus infection. J. Infect. Dis. 203:12 (2011), 1775–1783.
27. Dejnirattisai, W., Wongwiwat, W., Supasa, S., Zhang, X., Dai, X., Rouvinsky, A., Jumnainsong, A., Edwards, C., Quyen, N.T., Duangchinda, T., Grimes, J.M., Tsai, W.Y., Lai, C.Y., Wang, W.K., Malasit, P., Farrar, J., Simmons, C.P., Zhou, Z.H., Rey, F.A., Mongkolsapaya, J., Screaton, G.R., A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16:2 (2015), 170–177.
28. Dhodapkar, K.M., Krasovsky, J., Williamson, B., Dhodapkar, M.V., Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. 195:1 (2002), 125–133.
29. Durbin, A.P., Vargas, M.J., Wanionek, K., Hammond, S.N., Gordon, A., Rocha, C., Balmaseda, A., Harris, E., Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376:2 (2008), 429–435.
30. Engering, A., van Vliet, S.J., Hebeda, K., Jackson, D.G., Prevo, R., Singh, S.K., Geijtenbeek, T.B., van Krieken, H., van Kooyk, Y., Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am. J. Pathol. 164:5 (2004), 1587–1595.
31. Figdor, C.G., van Kooyk, Y., Adema, G.J., C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2:2 (2002), 77–84.
32. Flipse, J., Wilschut, J., Smit, J.M., Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic 14:1 (2013), 25–35.
33. Flipse, J., Torres, S., Diosa-Toro, M., van der Ende-Metselaar, H., Herrera-Rodriguez, J., Urcuqui-Inchima, S., Huckriede, A., Rodenhuis-Zybert, I.A., Smit, J.M., Dengue tropism for macrophages and dendritic cells: the host cell effect. J. Gen. Virol., 2016, 10.1099/jgv.0.000474.
34. Geissmann, F., Manz, M.G., Jung, S., Sieweke, M.H., Merad, M., Ley, K., Development of monocytes, macrophages, and dendritic cells. Science 327:5966 (2010), 656–661.
35. Gijzen, K., Tacken, P.J., Zimmerman, A., Joosten, B., de Vries, I.J., Figdor, C.G., Torensma, R., Relevance of DC-SIGN in DC-induced T cell proliferation. J. Leukoc. Biol. 81:3 (2007), 729–740.
36. Green, S., Vaughn, D.W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B.L., Kurane, I., Rothman, A.L., Ennis, F.A., Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 174 (1999), 755–762.
37. Guzman, M.G., Kouri, G.P., Bravo, J., Soler, M., Vazquez, S., Morier, L., Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42:2 (1990), 179–184.
38. Guzman, M.G., Halstead, S.B., Artsob, H., Buchy, P., Farrar, J., Gubler, D.J., Hunsperger, E., Kroeger, A., Margolis, H.S., Martinez, E., Nathan, M.B., Pelegrino, J.L., Simmons, C., Yoksan, S., Peeling, R.W., Dengue: a continuing global threat. Nat. Rev. Microbiol. 8:Suppl. 12 (2010), S7–16.
39. Guzman, M.G., Alvarez, M., Halstead, S.B., Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol 158:7 (2013), 1445–1459.
40. Hacker, K., White, L., de Silva, A.M., N-linked glycans on dengue viruses grown in mammalian and insect cells. J. Gen. Virol. 90:Pt. 9 (2009), 2097–2106.
41. Halstead, S.B., Dengue. Curr. Opin. Infect. Dis. 15:5 (2002), 471–476.
42. Halstead, S.B., Controversies in dengue pathogenesis. Paediatr. Int. Child Health 32:Suppl. 1 (2012), 5–9.
43. Halstead, S.B., O'Rourke, E.J., Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:1 (1977), 201–217.
44. Hatch, S., Endy, T.P., Thomas, S., Mathew, A., Potts, J., Pazoles, P., Libraty, D.H., Gibbons, R., Rothman, A.L., Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J. Infect. Dis. 203:9 (2011), 1282–1291.
45. Henriques, H.R., Rampazo, E.V., Goncalves, A.J., Vicentin, E.C., Amorim, J.H., Panatieri, R.H., Amorim, K.N., Yamamoto, M.M., Ferreira, L.C., Alves, A.M., Boscardin, S.B., Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl. Trop. Dis., 7(7), 2013, e2330.
46. Ho, L.J., Wang, J.J., Shaio, M.F., Kao, C.L., Chang, D.M., Han, S.W., Lai, J.H., Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:3 (2001), 1499–1506.
47. Ho, L.J., Hung, L.F., Weng, C.Y., Wu, W.L., Chou, P., Lin, Y.L., Chang, D.M., Tai, T.Y., Lai, J.H., Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 174:12 (2005), 8163–8172.
48. Hopkins, R.A., Connolly, J.E., The specialized roles of immature and mature dendritic cells in antigen cross-presentation. Immunol. Res. 53:1-3 (2012), 91–107.
49. Jessie, K., Fong, M.Y., Devi, S., Lam, S.K., Wong, K.T., Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189:8 (2004), 1411–1418.
50. Jones, M., Davidson, A., Hibbert, L., Gruenwald, P., Schlaak, J., Ball, S., Foster, G.R., Jacobs, M., Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79:9 (2005), 5414–5420.
51. Kliks, S.C., Nimmanitya, S., Nisalak, A., Burke, D.S., Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:2 (1988), 411–419.
52. Kou, Z., Lim, J.Y., Beltramello, M., Quinn, M., Chen, H., Liu, S., Martinez-Sobrido, L., Diamond, M.S., Schlesinger, J.J., de Silva, A., Sallusto, F., Jin, X., Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology 410:1 (2011), 240–247.
53. Kurane, I., Ennis, F.A., Production of interferon alpha by dengue virus-infected human monocytes. J. Gen. Virol. 69:Pt. 2 (1988), 445–449.
54. Kyle, J.L., Beatty, P.R., Harris, E., Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J. Infect. Dis. 195:12 (2007), 1808–1817.
55. Kyle, J.L., Balsitis, S.J., Zhang, L., Beatty, P.R., Harris, E., Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380:2 (2008), 296–303.
56. Li, L., Lok, S.M., Yu, I.M., Zhang, Y., Kuhn, R.J., Chen, J., Rossmann, M.G., The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319:5871 (2008), 1830–1834.
57. Libraty, D.H., Pichyangkul, S., Ajariyakhajorn, C., Endy, T.P., Ennis, F.A., Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75:8 (2001), 3501–3508.
58. Littaua, R., Kurane, I., Ennis, F.A., Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:8 (1990), 3183–3186.
59. Liu, K., Nussenzweig, M.C., Origin and development of dendritic cells. Immunol. Rev. 234:1 (2010), 45–54.
60. Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M.A., Garcia-Sastre, A., Katze, M.G., Gale, M. Jr., Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:1 (2008), 335–345.
61. Lozach, P.Y., Burleigh, L., Staropoli, I., Navarro-Sanchez, E., Harriague, J., Virelizier, J.L., Rey, F.A., Despres, P., Arenzana-Seisdedos, F., Amara, A., Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280:25 (2005), 23698–23708.
62. Mackenzie, J.M., Jones, M.K., Young, P.R., Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220:1 (1996), 232–240.
63. Malavige, G.N., Gomes, L., Alles, L., Chang, T., Salimi, M., Fernando, S., Nanayakkara, K.D., Jayaratne, S., Ogg, G.S., Serum IL-10 as a marker of severe dengue infection. BMC Infect. Dis., 13, 2013, 341.
64. Martina, B.E., Koraka, P., Osterhaus, A.D., Dengue virus pathogenesis: an integrated view. Clin. Microbiol. Rev. 22:4 (2009), 564–581.
65. Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31 (2013), 563–604.
66. Miller, J.L., de Wet, B.J., Martinez-Pomares, L., Radcliffe, C.M., Dwek, R.A., Rudd, P.M., Gordon, S., The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog., 4(2), 2008, e17.
67. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Structure of the dengue virus envelope protein after membrane fusion. Nature 427:6972 (2004), 313–319.
68. Mohamad Zamberi, Z., Zakaria, Z., Abdul Aziz, A.T., Heng, B.S., Zaid, M., Chong, C.L., Noor, F.M., Abu Bakar, S., Boon Peng, H., The high-affinity human IgG receptor Fc gamma receptor I (FcgammaRI) is not associated with vascular leakage of dengue. J. Negat. Results Biomed., 14, 2015, 1.
69. Moi, M.L., Lim, C.K., Takasaki, T., Kurane, I., Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J. Gen. Virol. 91:Pt. 1 (2010), 103–111.
70. Moi, M.L., Lim, C.K., Kotaki, A., Takasaki, T., Kurane, I., Detection of higher levels of dengue viremia using FcgammaR-expressing BHK-21 cells than FcgammaR-negative cells in secondary infection but not in primary infection. J. Infect. Dis. 203:10 (2011), 1405–1414.
71. Mongkolsapaya, J., Dejnirattisai, W., Xu, X.N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., Yenchitsomanus, P.T., McMichael, A., Malasit, P., Screaton, G., Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:7 (2003), 921–927.
72. Morrison, J., Laurent-Rolle, M., Maestre, A.M., Rajsbaum, R., Pisanelli, G., Simon, V., Mulder, L.C., Fernandez-Sesma, A., Garcia-Sastre, A., Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog., 9(3), 2013, e1003265.
73. Mukherjee, S., Lin, T.Y., Dowd, K.A., Manhart, C.J., Pierson, T.C., The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases. J. Virol. 85:22 (2011), 12067–12072.
74. Munoz-Jordan, J.L., Sanchez-Burgos, G.G., Laurent-Rolle, M., Garcia-Sastre, A., Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. U. S. A. 100:24 (2003), 14333–14338.
75. Munoz-Jordan, J.L., Laurent-Rolle, M., Ashour, J., Martinez-Sobrido, L., Ashok, M., Lipkin, W.I., Garcia-Sastre, A., Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:13 (2005), 8004–8013.
76. Nasirudeen, A.M., Wong, H.H., Thien, P., Xu, S., Lam, K.P., Liu, D.X., RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl. Trop. Dis., 5(1), 2011, e926.
77. Navarro-Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J.L., Arenzana-Seisdedos, F., Despres, P., Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4:7 (2003), 723–728.
78. Nimmerjahn, F., Ravetch, J.V., Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8:1 (2008), 34–47.
79. Orozco, S., Schmid, M.A., Parameswaran, P., Lachica, R., Henn, M.R., Beatty, R., Harris, E., Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J. Gen. Virol. 93:Pt. 10 (2012), 2152–2157.
80. Pagni, S., Fernandez-Sesma, A., Evasion of the human innate immune system by dengue virus. Immunol. Res. 54:1–3 (2012), 152–159.
81. Pokidysheva, E., Zhang, Y., Battisti, A.J., Bator-Kelly, C.M., Chipman, P.R., Xiao, C., Gregorio, G.G., Hendrickson, W.A., Kuhn, R.J., Rossmann, M.G., Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124:3 (2006), 485–493.
82. Rafiq, K., Bergtold, A., Clynes, R., Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest. 110:1 (2002), 71–79.
83. Ravetch, J.V., Bolland, S., IgG Fc receptors. Annu. Rev. Immunol. 19 (2001), 275–290.
84. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., Amigorena, S., Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:2 (1999), 371–380.
85. Reizis, B., Bunin, A., Ghosh, H.S., Lewis, K.L., Sisirak, V., Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29 (2011), 163–183.
86. Reyes-Del Valle, J., Chavez-Salinas, S., Medina, F., Del Angel, R.M., Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79:8 (2005), 4557–4567.
87. Richter, M.K.S., da Silva Voorham, J.M., Torres Pedraza, S., Hoornweg, T.E., van de Pol, D.P.I., Rodenhuis-Zybert, I.A., Wilschut, J., Smit, J.M., Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. PLoS One, 9(6), 2014.
88. Rodrigo, W.W., Jin, X., Blackley, S.D., Rose, R.C., Schlesinger, J.J., Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J. Virol. 80:20 (2006), 10128–10138.
89. Rodrigo, W.W., Alcena, D.C., Kou, Z., Kochel, T.J., Porter, K.R., Comach, G., Rose, R.C., Jin, X., Schlesinger, J.J., Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin. Vaccine Immunol. 16:2 (2009), 285–287.
90. Rodriguez-Madoz, J.R., Bernal-Rubio, D., Kaminski, D., Boyd, K., Fernandez-Sesma, A., Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J. Virol. 84:9 (2010), 4845–4850.
91. Rosales, C., Uribe-Querol, E., Fc receptors: cell activators of antibody functions. Adv. Biosci. Biotechnol. 4 (2013), 21–33.
92. Sakuntabhai, A., Turbpaiboon, C., Casademont, I., Chuansumrit, A., Lowhnoo, T., Kajaste-Rudnitski, A., Kalayanarooj, S.M., Tangnararatchakit, K., Tangthawornchaikul, N., Vasanawathana, S., Chaiyaratana, W., Yenchitsomanus, P.T., Suriyaphol, P., Avirutnan, P., Chokephaibulkit, K., Matsuda, F., Yoksan, S., Jacob, Y., Lathrop, G.M., Malasit, P., Despres, P., Julier, C., A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37:5 (2005), 507–513.
93. Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:2 (1995), 389–400.
94. Schaeffer, E., Flacher, V., Papageorgiou, V., Decossas, M., Fauny, J.D., Kramer, M., Mueller, C.G., Dermal CD14(+) dendritic cell and macrophage infection by dengue virus is stimulated by interleukin-4. J. Invest. Dermatol. 135:7 (2015), 1743–1751.
95. Schlitzer, A., McGovern, N., Ginhoux, F., Dendritic cells and monocyte-derived cells: two complementary and integrated functional systems. Semin. Cell Dev. Biol. 41 (2015), 9–22.
96. Schmid, M.A., Harris, E., Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication. PLoS Pathog., 10(12), 2014, e1004541.
97. Schoggins, J.W., Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 6 (2014), 40–46.
98. Shi, C., Pamer, E.G., Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11:11 (2011), 762–774.
99. Shortman, K., Liu, Y.J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:3 (2002), 151–161.
100. Shortman, K., Naik, S.H., Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:1 (2007), 19–30.
101. Silveira, G.F., Strottmann, D.M., de Borba, L., Mansur, D.S., Zanchin, N.I., Bordignon, J., Duarte Dos Santos, C.N., Single point mutations in the helicase domain of the NS3 protein enhance dengue virus replicative capacity in human monocyte-derived dendritic cells and circumvent the type I interferon response. Clin. Exp. Immunol. 183:1 (2016), 114–128.
102. Soilleux, E.J., Morris, L.S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L.J., Doms, R.W., Weissman, D., Coleman, N., Lee, B., Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71:3 (2002), 445–457.
103. Stadler, K., Allison, S.L., Schalich, J., Heinz, F.X., Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71:11 (1997), 8475–8481.
104. Steinman, R.M., Hemmi, H., Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311 (2006), 17–58.
105. Stephenson, J.R., Understanding dengue pathogenesis: implications for vaccine design. Bull. World Health Organ. 83:4 (2005), 308–314.
106. Suda, S., Williams, H., Medbury, H.J., Holland, A.J., A review of monocytes and monocyte-Derived cells in hypertrophic scarring post burn. J. Burn Care Res., 2015, 10.1097/BCR.0000000000000312.
107. Sun, P., Fernandez, S., Marovich, M.A., Palmer, D.R., Celluzzi, C.M., Boonnak, K., Liang, Z., Subramanian, H., Porter, K.R., Sun, W., Burgess, T.H., Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383:2 (2009), 207–215.
108. Sunit Singhi, N.K., Bansal, Arun, Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J. Pediatr., 83(2), 2007.
109. Tassaneetrithep, B., Burgess, T.H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M.A., Pattanapanyasat, K., Sarasombath, S., Birx, D.L., Steinman, R.M., Schlesinger, S., Marovich, M.A., DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:7 (2003), 823–829.
110. Thomas, S.J., Endy, T.P., Critical issues in dengue vaccine development. Curr. Opin. Infect. Dis. 24:5 (2011), 442–450.
111. Torres, S., Hernandez, J.C., Giraldo, D., Arboleda, M., Rojas, M., Smit, J.M., Urcuqui-Inchima, S., Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease. PLoS Negl. Trop. Dis., 7(2), 2013, e2060.
112. Tsai, Y.T., Chang, S.Y., Lee, C.N., Kao, C.L., Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell. Microbiol. 11:4 (2009), 604–615.
113. Tsai, T.T., Chuang, Y.J., Lin, Y.S., Wan, S.W., Chen, C.L., Lin, C.F., An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J. Biomed. Sci., 20, 2013, 40.
114. Tsai, T.T., Chuang, Y.J., Lin, Y.S., Chang, C.P., Wan, S.W., Lin, S.H., Chen, C.L., Lin, C.F., Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS Negl Trop Dis, 8(11), 2014, e3320.
115. van den Broek, M.F., Muller, U., Huang, S., Aguet, M., Zinkernagel, R.M., Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:8 (1995), 4792–4796.
116. van der Schaar, H.M., Rust, M.J., Waarts, B.L., van der Ende-Metselaar, H., Kuhn, R.J., Wilschut, J., Zhuang, X., Smit, J.M., Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J. Virol. 81:21 (2007), 12019–12028.
117. van Vliet, S.J., Garcia-Vallejo, J.J., van Kooyk, Y., Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunol. Cell Biol. 86:7 (2008), 580–587.
118. Wang, J.P., Liu, P., Latz, E., Golenbock, D.T., Finberg, R.W., Libraty, D.H., Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J. Immunol. 177:10 (2006), 7114–7121.
119. Watarai, H., Hinohara, A., Nagafune, J., Nakayama, T., Taniguchi, M., Yamaguchi, Y., Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 5:15 (2005), 4001–4011.
120. Weiskopf, D., Angelo, M.A., de Azeredo, E.L., Sidney, J., Greenbaum, J.A., Fernando, A.N., Broadwater, A., Kolla, R.V., De Silva, A.D., de Silva, A.M., Mattia, K.A., Doranz, B.J., Grey, H.M., Shresta, S., Peters, B., Sette, A., Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. U. S. A. 110:22 (2013), E2046–2053.
121. Whitehead, S.S., Blaney, J.E., Durbin, A.P., Murphy, B.R., Prospects for a dengue virus vaccine. Nat. Rev. Microbiol. 5:7 (2007), 518–528.
122. WHO, 2009. Dengue. Guidelines for diagnosis, treatment prevention and control. 3rd edn.
123. Wu, S.J., Grouard-Vogel, G., Sun, W., Mascola, J.R., Brachtel, E., Putvatana, R., Louder, M.K., Filgueira, L., Marovich, M.A., Wong, H.K., Blauvelt, A., Murphy, G.S., Robb, M.L., Innes, B.L., Birx, D.L., Hayes, C.G., Frankel, S.S., Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:7 (2000), 816–820.
124. Yu, I.M., Zhang, W., Holdaway, H.A., Li, L., Kostyuchenko, V.A., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., Chen, J., Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319 (2008), 1834–1837.
125. Zhou, Y., Deng, H.W., Shen, H., Circulating monocytes: an appropriate model for bone-related study. Osteoporos. Int. 26:11 (2015), 2561–2572.
126. Zompi, S., Montoya, M., Pohl, M.O., Balmaseda, A., Harris, E., Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl. Trop. Dis., 6(3), 2012, e1568.
127. Zompi, S., Santich, B.H., Beatty, P.R., Harris, E., Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J. Immunol. 188:1 (2012), 404–416.